Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Artara Therapeutics Inc (NQ: TARA )

2.930 -0.050 (-1.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 251,322
Open 2.980
Bid (Size) 2.960 (4)
Ask (Size) 3.200 (5)
Prev. Close 2.980
Today's Range 2.870 - 3.200
52wk Range 1.040 - 5.240
Shares Outstanding 11,235,731
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates, adverse events, and future plans. Stay updated on Protara Therapeutics' advancements in cancer... 
Via Benzinga
Exposures Product Safety

Performance

YTD
+39.52%
+39.52%
1 Month
-29.23%
-29.23%
3 Month
+14.90%
+14.90%
6 Month
+144.17%
+144.17%
1 Year
-6.98%
-6.98%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
3 Stocks That Could Help You Retire on a Private Island
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Recap: Protara Therapeutics Q1 Earnings
Via Benzinga
Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer
Via Benzinga
Protara Therapeutics Shares Retrospective Analysis Of OK-432 In Rare Lymphatic Malformations
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Protara Therapeutics: Q3 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Via InvestorPlace
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Recap: Protara Therapeutics Q4 Earnings
Via Benzinga
11 Things to Know About Protara Therapeutics as TARA Stock Soars on Big FDA News
Via InvestorPlace
Exposures Product Safety
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.